The chart is not accessible to screen readers. Please switch to the table view to access the data.
Advertisement
Advertisement
Logistics spending in the global biopharma industry between 2016 and 2022, by cold chain vs. non-cold chain (in billion U.S. dollars)
Global biopharma logistics spending forecast by chain type 2016-2022
The global biopharmaceutical industry's spending on cold chain logistics is projected to reach nearly 19 billion U.S. dollars by 2022. This would be a significant increase compared some 13 billion dollars back in 2016.
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Statistics on
About the industry
10
- Basic Statistic Global biopharma spending on transport and packaging 2018
- Basic Statistic Global biopharma spending on cold chain transport by mode 2018
- Basic Statistic Biopharma global sales forecast by chain type 2016-2022
- Premium Statistic Percentage return on R&D among large cap biopharma companies 2010-2020
- Basic Statistic Percentage return on R&D among mid cap biopharma companies 2013-2020
- Premium Statistic Cost to bring large cap biopharmaceutical assets to market 2010-2020
- Basic Statistic 3 year average R&D cost to develop new biopharmaceutical compounds 2010-2020
- Basic Statistic R&D cost to develop new pharmaceutical compounds 2010-2020
- Premium Statistic Market revenue from type 2 diabetes pharmaceuticals by region 2012-2022
- Premium Statistic Breakdown of biotech and pharma CEO compensation 2018, by component
About the region
10
- Basic Statistic Orphan drug sales worldwide by therapy category 2030
- Premium Statistic Orphan vs. non-orphan drugs median cost per patient per year 2014-2018
- Basic Statistic Top global orphan drugs by revenue 2018
- Premium Statistic Revenue forecast for global biologics market 2016-2022
- Basic Statistic Worldwide Rx drug sales excluding generics and orphan drugs 2012-2026
- Basic Statistic Average prices of Gleevec - selected countries 2013
- Basic Statistic Annual revenues of BRICS country pharmaceutical industry 2013-2015
- Basic Statistic Top biotech & pharma firms by median employee pay 2019
- Basic Statistic Select mid-size biotech firms by CEO compensation 2019
- Basic Statistic Number of startups using AI in drug discovery worldwide 2019, by area of discovery
Selected statistics
10
- Premium Statistic Average peak sales forecast per new biopharmaceutical asset 2013-2025
- Premium Statistic Average R&D cost to develop new biopharma compound 2013-2025
- Premium Statistic Top global companies by orphan drug revenues 2024
- Basic Statistic GSK revenue by division 2006-2024
- Premium Statistic Top U.S. pharmaceutical patent expiries by revenue 2014-2016
- Basic Statistic Projected top pharmaceutical companies based on new sales 2023
- Basic Statistic Market capitalization change in key COVID-19 firms until end-May 2020
- Premium Statistic GSK's revenue 2013-2025, by region
- Premium Statistic U.S. biopharmaceutical export volume 2002-2025
- Premium Statistic Patent expiration risk for total worldwide global Rx drug revenue 2018-2032
Other regions
10
- Basic Statistic Biotech firms active in COVID-19 R&D in Italy 2020, by product
- Premium Statistic Number of pharmaceutical products manufacturing enterprises in Poland 2020-2023
- Basic Statistic Leading U.S. pharmaceutical products by revenue 2026
- Basic Statistic Medicare Part D coverage gap cost-sharing for brand and generic drugs 2019
- Premium Statistic Sold production value of pharmaceutical products in Poland 2005-2023
- Basic Statistic Biopharmaceutical industry impact on labor income U.S. 2022
- Basic Statistic Impact of the U.S. biopharmaceutical industry on federal personal tax revenues 2022
- Basic Statistic Biopharmaceutical industry impact on output U.S. 2022
- Basic Statistic Biopharmaceutical industry impact on added value U.S. 2022
- Basic Statistic Biopharmaceutical industry impact on state/local tax revenues U.S. 2022
Related statistics
10
- Premium Statistic Developed pharmaceutical market CAGR by country 2012-2017
- Premium Statistic Total number of pharma merger and acquisition deals 2020-2024
- Premium Statistic Average prices of Nexium - selected countries 2013
- Premium Statistic Value of pharma and biotech merger and acquisition deals 2020-2024
- Premium Statistic Global biotechnology revenue by region 2012
- Basic Statistic Number of biopharma venture financing deals 2017-2022
- Premium Statistic Top pharma companies by sales loss due to patent loss until 2018
- Premium Statistic Widest CEO-employee pay gap among biopharmaceutical firms 2019
- Premium Statistic Leading pharmaceutical companies' SG&A to revenue rate 2024
- Basic Statistic Impact of U.S. biopharmaceutical industry on employment 2022
Further Content: You might find this interesting as well
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Pharmaceutical Commerce. (September 3, 2018). Logistics spending in the global biopharma industry between 2016 and 2022, by cold chain vs. non-cold chain (in billion U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 24, 2026, from /statistics/1073945/forecast-on-global-biopharma-logistics-spending-by-chain-type/
Pharmaceutical Commerce. "Logistics spending in the global biopharma industry between 2016 and 2022, by cold chain vs. non-cold chain (in billion U.S. dollars)." Chart. September 3, 2018. ÌÇÐÄÆƽâ°æ. Accessed July 24, 2026. /statistics/1073945/forecast-on-global-biopharma-logistics-spending-by-chain-type/
Pharmaceutical Commerce. (2018). Logistics spending in the global biopharma industry between 2016 and 2022, by cold chain vs. non-cold chain (in billion U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 24, 2026. /statistics/1073945/forecast-on-global-biopharma-logistics-spending-by-chain-type/
Pharmaceutical Commerce. "Logistics Spending in The Global Biopharma Industry between 2016 and 2022, by Cold Chain Vs. Non-cold Chain (in Billion U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 3 Sep 2018, /statistics/1073945/forecast-on-global-biopharma-logistics-spending-by-chain-type/
Pharmaceutical Commerce, Logistics spending in the global biopharma industry between 2016 and 2022, by cold chain vs. non-cold chain (in billion U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/1073945/forecast-on-global-biopharma-logistics-spending-by-chain-type/ (last visited July 24, 2026)
Logistics spending in the global biopharma industry between 2016 and 2022, by cold chain vs. non-cold chain (in billion U.S. dollars) [Graph], Pharmaceutical Commerce, September 3, 2018. [Online]. Available: /statistics/1073945/forecast-on-global-biopharma-logistics-spending-by-chain-type/
Advertisement